Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Schizophrenia gene controls when new neurones mature

23 March 2009

By Rose Palmer

Appeared in BioNews 500

Researchers at the Massachusetts Institute of Technology (MIT) Picower Institute for Learning and Memory in the US have found that a gene commonly associated with schizophrenia is essential for normal brain development and the growth of new neurons. The finding was reported in the journal Cell and could help lead to new treatments for the disorder, which affects up to one per cent of adults worldwide and is characterised by hallucinations, delusions, paranoia and depression.

The team, led by Li-Huei Tsai, the Picower Professor of Neuroscience, has shown for the first time that a gene known as DISC1 (disrupted in schizophrenia1) directly inhibits an enzyme called GSK3B (glycogen synthase kinase 3 beta). For decades doctors have treated bipolar disorder using lithium chloride treatments that target this enzyme.

The DISC1 gene was first identified in the 1990s when scientists studied a large Scottish family with mental disorders. They found that many of the family members who developed psychiatric disorders carried a mutation in the gene.

In a series of studies Tsai and colleagues found that DISC1 regulates the balance between neural stem cell self renewal and turning into neurons. A defective gene affects this balance and can lead to compromised cognition and behavioural abnormalities.

Tsai said: 'During brain development, a fine tuned mechanism regulates when neural stem cells divide and replenish their own population and when they turn into new neurons that will mature and grow appropriate connections with other neurons.'

The researchers found that the DISC1 gene is highly expressed in embryonic mice brain stem cells and also in the brain stem cells of adult mice. But when they inhibited the expression of DISC1, simulating what is occurring when someone carries a defective gene, it caused the stem cells to stop dividing and prematurely turn into newborn neurons.

In adult mice inhibition of DISC1 also produced behavioural side effects that were symptomatic of schizophrenia. For example the mice skittered around their cages, a behaviour which is often paralleled with mania in humans. These behavioural abnormalities were reversed when the DISC1 deficient mice were treated with a chemical inhibitor of GSK3B.

Tsai said that the findings are part of a larger picture of the genetic and developmental causes of psychological disorders. 'With this new knowledge of the DISC1-GSK3B interaction, one of the goals is to develop new drugs targeting schizophrenia, providing some hope that this devastating disease will be treated more effectively in the future,' she said.

SOURCES & REFERENCES
ScienceDaily | 20 March 2009
 
BBC News Online | 21 March 2009
 
Howard Hills Medical Institute | 20 March 2009
 
EurekAalert | 19 March 2009
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

07 April 2014 - by Dr Naqash Raja 
A map showing where different genes are turned on and off in the fetal human brain has been published in the hope it will give important clues about the origins of disorders...

19 January 2009 - by Ailsa Stevens 
Schizophrenia and bipolar disorder (previously manic depression) may be different manifestations of the same disease, according to a new study published in The Lancet medial journal last week. While hundreds or even thousands of genes, plus environmental factors, may contribute to the development of either condition, some...
01 August 2008 - by Ailsa Stevens 
Three independent studies have identified gene variants which contribute significantly to schizophrenia risk, taking steps towards understanding the cause of this highly complex condition which affects 1 in 100 people. Two of the three gene variants discovered were rare, but conferred 12 and 15 percent higher risks...
31 March 2008 - by Ailsa Stevens 
Two independent studies published in the journal Science this week suggest that many rare gene mutations may be responsible for causing schizophrenia, challenging the widely held theory that combinations of several relatively common mutations are to blame. The researchers found that very rare genetic disruptions, often unique...
10 December 2007 - by Ailsa Stevens 
US researchers at the Feinstein Institute for Medical Research last week reported the discovery of nine new genetic markers for schizophrenia. The study - published in the journal Proceedings of the National Academy of Sciences - used a novel whole genome scanning method to identify sections of genetic code...
18 November 2005 - by BioNews 
Scottish researchers have identified another gene involved in schizophrenia and bipolar disorder (manic depression), a discovery that could lead to new drug treatments for the conditions. The team, based at the Universities of Edinburgh and Glasgow, has shown that an altered version of a gene called PDE4B is linked to...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation